Seeing an asthma specialist (chi(2)(1) 24 07, p < 001), was a

Seeing an asthma specialist (chi(2)(1) 24.07, p < .001), was associated with having a plan. Women who did not have a negotiated treatment plan at baseline, but acquired one at 12 or 24 months, were more likely to report greater urgent office visits for asthma (odds ratio (OR) 1.37, 95% confidence interval (CI) 1.07-1.61). No associations were observed between having a plan and urgent healthcare use or symptom frequency. When adjusting for household check details income, level of asthma control, and specialty of the caregiving provider, women who did not have a negotiated treatment plan (OR = 0.28, 95% CI = 0.09-0.79) and those with a plan at

fewer than three time points (OR = 0.30, 95% CI = 0.11-0.83) were less likely to report medication adherence and satisfaction with their care (regression coefficient (standard error) = -0.65 (0.17), p < .001). No differences in asthma management self-efficacy

or asking the doctor questions about asthma were observed. Conclusion. Women with asthma who had a negotiated treatment plan were more likely to see an asthma specialist. In the long-term, not having a treatment plan that is developed in partnership with a clinician may have an adverse impact on medication use and patient views of clinical services.”
“Objective. To examine the association between maternal thrombophilia associated with anticoagulation 5-Fluoracil datasheet (proteins C and S and activated protein C resistance ratio, APCR) and risk of placental abruption.

Methods. Data were derived from a case-control study – MLN0128 ic50 The New Jersey-Placental Abruption Study (2002-2007). Maternal blood was collected from abruption cases and controls and was assayed for the thrombophilias.

Decreased protein C, S and APCR was defined as values < 5% and < 10% among controls.

Results. Of a total of 132 cases and 127 controls, 3 were heterozygous for the factor V Leiden mutation (1 case and 2 controls). Mean (+/- standard deviation) protein C (114.2 +/- 25.6 vs. 121.4 +/- 27.6; P = 0.009), protein S (39.9 +/- 18.4 vs. 35.7 +/- 15.2; P = 0.043) and APCR (2.86 +/- 0.29 vs. 2.88 +/- 0.27; P = 0.039) were different between cases and controls. Abruption cases were associated with an odds ratio of 3.2 (95% CI 1.2, 9.9) in relation to decreased protein C (< Fifth centile). Decreases in both protein S and APCR ratio were not associated with abruption.

Conclusions. A decrease in protein C was associated with an increased risk for abruption, suggesting an important role for the physiologic anticoagulant system in the etiology of placental abruption.”
“OBJECTIVE: To assess the presence of metabolic disorders in elderly men with urolithiasis.

METHODS: We performed a case-control study. The inclusion criteria were as follows: (1) men older than 60 years of age and either (2) antecedent renal colic or an incidental diagnosis of urinary lithiasis after age 60 (case arm) or (3) no antecedent renal colic or incidental diagnosis of urolithiasis (control arm).

Comments are closed.